Your browser doesn't support javascript.
loading
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey.
Bajema, Kristina L; Dahlgren, F Scott; Lim, Travis W; Bestul, Nicolette; Biggs, Holly M; Tate, Jacqueline E; Owusu, Claudio; Szablewski, Christine M; Drenzek, Cherie; Drobeniuc, Jan; Semenova, Vera; Li, Han; Browning, Peter; Desai, Rita; Epperson, Monica; Jia, Lily T; Thornburg, Natalie J; Edens, Chris; Fry, Alicia M; Hall, Aron J; Schiffer, Jarad; Havers, Fiona P.
Afiliação
  • Bajema KL; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Dahlgren FS; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Lim TW; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Bestul N; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Biggs HM; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Tate JE; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Owusu C; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Szablewski CM; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Drenzek C; Georgia Department of Public Health, Atlanta, Georgia, USA.
  • Drobeniuc J; Georgia Department of Public Health, Atlanta, Georgia, USA.
  • Semenova V; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Li H; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Browning P; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Desai R; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Epperson M; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Jia LT; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Thornburg NJ; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Edens C; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Fry AM; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Hall AJ; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Schiffer J; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Havers FP; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis ; 73(9): e3120-e3123, 2021 11 02.
Article em En | MEDLINE | ID: mdl-33300579
We compared severe acute respiratory syndrome coronavirus 2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April and May 2020 and found these 2 estimates to be similar (4.94% vs 3.18%). Compared with more representative surveys, commercial sera can provide an approximate measure of seroprevalence.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos